Efficacy of verdinexor for the treatment of naïve canine epitheliotropic cutaneous T-cell lymphoma: An open-label pilot study.
Elana M VlodaverM Kelly KeatingWillie A BidotDavid S BruyetteWayne S RosenkrantzPublished in: Veterinary dermatology (2024)
Verdinexor could be considered a safe, palliative treatment for canine CETL.
Keyphrases